Statin Use for the Primary Prevention of Cardiovascular Dise

This 2022 Recommendation Statement from the US Preventive Services Task Force recommends that for primary prevention of cardiovascular disease (CVD) in adults a

Related Keywords

United States , New York , University School , Pennsylvania , United Kingdom , University Of Massachusetts Medical School , Massachusetts , New York University , Boston , California , Scotland , American , Mali , James Stevermer , Esam Davis , David Chelmow , Wandak Nicholson , Gbenga Ogedegbe , Carolm Mangione , Worcester Pbert , Tumaini Rucker Coker , Seattle Coker , Los Angeles , Michael Cabana , Katrinae Donahue , Carlos Roberto Ja , Antonio Ja , Johnm Ruiz , Michaelj Barry , Richmond Chelmow , Charlottesville Li , Martha Kubik , Johnb Wong , Lori Pbert , Los Angeles Mangione , Lisa Nicolella , Department Of Health , York University , American College Of Cardiology Heart Association , Us Congress , Centers For Disease , George Mason University , Albert Einstein College Of Medicine , Practice Center , Harvard Medical School , Journal Of The American Medical Association , Research Needs , University Of Arizona , Agency For Healthcare Research , University Of California , National Health , Us Preventive Services Task Force , University Of Missouri , Women Health Initiative , University Of Washington , University Of Pittsburgh , United States Preventive Services Task Force , Us Department Of Health , University Of Virginia , Nutrition Examination , National Center , Human Services , David Geffen School Of Medicine , Virginia Commonwealth University , University Of Texas Health Science Center , Tufts University School Of Medicine , Health Statistics , Services Task Force , Net Benefit , Population Under Consideration , American College , American Heart Association , Pooled Cohort Equations , Statin Intensity , Nutrition Examination Survey , Hispanic White , Hispanic Asian , Hispanic Black , Disease Control , Practice Regarding , Preventable Burden , Intervention Trial Evaluating Rosuvastatin , Preventive Medication , Prospective Study , Scotland Coronary Prevention Study , Lipid Lowering Treatment , Prevent Heart Attack Trial , Lipid Lowering Trial , Health Initiative , Public Comment , Practice Considerations , South Asian , Defense Clinical Practice Guideline , David Geffen School , North Carolina , Chapel Hill , Albert Einstein College , Texas Health Science Center , San Antonio , Massachusetts Medical School , Tufts University School , Interest Disclosures , Healthcare Research , Evidence Based Practice Center , Howard Tracer , American Medical Association , United States Government ,